September 5, 2022 AOK has begun a new program with German Society for Pain Medicine to decrease approval complexity, while Barmer has just issued a new digital section on its website on the medical efficacy of cannabis. Has the tide turned on insurer resistance to medical underwriting of cannabis claims?
There is clearly something afoot with German health insurers when it comes to medical cannabis this fall. Perhaps it is the change in political winds on a national level with pending draft legislation on recreational use – which will ensure that cannabis is a part of the wellness if not healthcare discussion permanently. Perhaps it is that patients have refused to stop suing their health insurers – or that doctors have not stopped prescribing.